CD19-CD34 tagged metabolically programmed CAR T cells
Term · Oncology and biomedicine · MLC-T-ONC-012377
A preparation of a subset of T lymphocytes, that are metabolically enhanced based on selection and purification on CD34 expression and primed to contain T-helper subset 1 and 17 (Th1/17 hybrid cells), that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, CD19-CD34tagged metabolically programmed CAR T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies. These T cells may show enhanced persistence and effector function as compared to other, non-metabolically enhanced, anti-CD19 CAR T cells.
| Identifier | MLC-T-ONC-012377 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | anti-CD19 CAR-expressing CD34tagged metabolically programmed T cells; CD19-CD34t metabolically programmed CAR T cells; CD34-selected metabolically fit CD19 CAR T cells; metabolically programmed CD19 CAR-T cells |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012377",
"term": "CD19-CD34 tagged metabolically programmed CAR T cells",
"field": "Oncology and biomedicine",
"definition": "A preparation of a subset of T lymphocytes, that are metabolically enhanced based on selection and purification on CD34 expression and primed to contain T-helper subset 1 and 17 (Th1/17 hybrid cells), that have been genetically modified to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, CD19-CD34tagged metabolically programmed CAR T cells target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. CD19 is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies. These T cells may show enhanced persistence and effector function as compared to other, non-metabolically enhanced, anti-CD19 CAR T cells.",
"synonyms": [
"anti-CD19 CAR-expressing CD34tagged metabolically programmed T cells",
"CD19-CD34t metabolically programmed CAR T cells",
"CD34-selected metabolically fit CD19 CAR T cells",
"metabolically programmed CD19 CAR-T cells"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cd19-cd34-tagged-metabolically-programmed-car-t-cells/"
}
Record 4,391 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.